Labeler
Zydus Pharmaceuticals USA Inc. NDC Codes
Zydus Pharmaceuticals USA Inc. lists 629 finished drug products in the FDA NDC Directory under NDC labeler codes 68382, 70710.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Isotretinoin, Riociguat, brivaracetam, tofacitinib, Eltrombopag, Beizray, Carbidopa and Levodopa, Jaythari, Deflazacort, Ascorbic acid, gadobutrol, Verapamil hydrochloride, Diazepam, gabapentin, oxcarbazepine
- Active ingredients
- Deflazacort, Isotretinoin, Riociguat, Brivaracetam, Tofacitinib citrate, Eltrombopag olamine, Carbidopa, Levodopa, Ascorbic acid, Gadobutrol, Verapamil hydrochloride, Diazepam
- NDC labeler codes
- 68382, 70710
- Strengths (from the 100 most recently listed products)
- Ascorbic acid 500 mg/mL; Gadobutrol 604.72 mg/mL; Docetaxel anhydrous 20 mg/mL; Deflazacort 22.75 mg/mL; Deflazacort 6 mg/1; Deflazacort 18 mg/1; Deflazacort 30 mg/1; Deflazacort 36 mg/1; Riociguat .5 mg/1; Riociguat 1 mg/1; Riociguat 1.5 mg/1; Riociguat 2 mg/1; Riociguat 2.5 mg/1; Fluvoxamine maleate 100 mg/1; Fluvoxamine maleate 150 mg/1; Sugammadex sodium 200 mg/2mL; Sugammadex sodium 500 mg/5mL; Ranibizumab .3 mg/.05mL; Ranibizumab .5 mg/.05mL; Tofacitinib citrate 10 mg/1
- Dosage forms
- Tablet, Tablet, Film coated, Injection, Injection, Solution, Capsule, Capsule, Extended release, Kit, Gel, Tablet, Extended release, Tablet, Film coated, Extended release, Suspension, Liquid, Tablet, For suspension, Powder, For solution
- Routes
- Oral, Intravenous, Intramuscular, Subcutaneous, Rectal, Intravitreal
- Drug classes (FDA established)
- Corticosteroid, Serotonin Reuptake Inhibitor, Retinoid, Soluble Guanylate Cyclase Stimulator, Janus Kinase Inhibitor, Thrombopoietin Receptor Agonist, Aromatic Amino Acid, Anti-epileptic Agent, Vitamin C, Gadolinium-based Contrast Agent, Calcium Channel Blocker, Benzodiazepine, Angiotensin 2 Receptor Blocker, Neprilysin Inhibitor, Tetracycline-class Drug, Vascular Endothelial Growth Factor Inhibitor, Diagnostic Dye, Nitrogen Binding Agent, Sodium-Glucose Cotransporter 2 Inhibitor, Endothelin Receptor Antagonist, Microtubule Inhibitor, CCR5 Co-receptor Antagonist, Kinase Inhibitor, Calcitonin, Oxidation-Reduction Agent, Phosphate Binder, Xanthine Oxidase Inhibitor, Arteriolar Vasodilator, Enzyme Stabilizer, Glucosylceramide Synthase Inhibitor
- HCPCS / J-code
- J2778 — Injection, ranibizumab, 0.1 mg
- Package NDCs
- 169 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| triamterene and hydrochlorothiazide | Triamterene 75 mg/1; Hydrochlorothiazide 50 mg/1 | TabletOral | 68382-857 | 68382-0857-0168382-0857-0568382-0857-10+1 more | — |
| Nifedipine | Nifedipine 30 mg/1 | Tablet, Extended releaseOral | 68382-688 | 68382-0688-0168382-0688-0568382-0688-10+3 more | — |
| Nifedipine | Nifedipine 60 mg/1 | Tablet, Extended releaseOral | 68382-689 | 68382-0689-0168382-0689-1068382-0689-16+2 more | — |
| Nifedipine | Nifedipine 90 mg/1 | Tablet, Extended releaseOral | 68382-690 | 68382-0690-0168382-0690-1068382-0690-16+2 more | — |
| spironolactone | Spironolactone 25 mg/1 | Tablet, Film coatedOral | 68382-660 | 68382-0660-0168382-0660-0568382-0660-06+3 more | — |
| spironolactone | Spironolactone 50 mg/1 | Tablet, Film coatedOral | 68382-661 | 68382-0661-0168382-0661-0568382-0661-06+3 more | — |
| spironolactone | Spironolactone 100 mg/1 | Tablet, Film coatedOral | 68382-662 | 68382-0662-0168382-0662-0568382-0662-06+3 more | — |
| Azithromycin | Azithromycin dihydrate 100 mg/5mL | Powder, For suspensionOral | 70710-1457 | 70710-1457-01 | — |
| Azithromycin | Azithromycin dihydrate 200 mg/5mL | Powder, For suspensionOral | 70710-1458 | 70710-1458-02 | — |
| Azithromycin | Azithromycin dihydrate 200 mg/5mL | Powder, For suspensionOral | 70710-1459 | 70710-1459-02 | — |
| Azithromycin | Azithromycin dihydrate 200 mg/5mL | Powder, For suspensionOral | 70710-1460 | 70710-1460-02 | — |
| bupropion | Bupropion hydrochloride 150 mg/1 | Tablet, Extended releaseOral | 68382-353 | 68382-0353-0568382-0353-0668382-0353-10+1 more | — |
| mesalamine | Mesalamine 800 mg/1 | Tablet, Delayed releaseOral | 68382-435 | 68382-0435-2868382-0435-77 | — |
| Cholestyramine | Cholestyramine 4 g/9g | Powder, For suspensionOral | 68382-528 | 68382-0528-4268382-0528-60 | — |
| metoprolol succinate | Metoprolol succinate 25 mg/1 | Tablet, Extended releaseOral | 68382-564 | 68382-0564-0168382-0564-0568382-0564-10 | — |
| metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | 68382-565 | 68382-0565-0168382-0565-0568382-0565-10 | — |
| metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | 68382-566 | 68382-0566-0168382-0566-0568382-0566-10 | — |
| metoprolol succinate | Metoprolol succinate 200 mg/1 | Tablet, Extended releaseOral | 68382-567 | 68382-0567-0168382-0567-0568382-0567-10 | — |
| Dutasteride and tamsulosin hydrochloride | Dutasteride .5 mg/1; Tamsulosin hydrochloride .4 mg/1 | CapsuleOral | 68382-640 | 68382-0640-0668382-0640-16 | — |
| Succinylcholine Chloride | Succinylcholine chloride 20 mg/mL | Injection, SolutionIntramuscular, Intravenous | 70710-1377 | 70710-1377-02 | — |
| bumetanide | Bumetanide .5 mg/1 | TabletOral | 68382-525 | 68382-0525-0168382-0525-0568382-0525-06+2 more | — |
| bumetanide | Bumetanide 1 mg/1 | TabletOral | 68382-526 | 68382-0526-0168382-0526-0568382-0526-06+2 more | — |
| bumetanide | Bumetanide 2 mg/1 | TabletOral | 68382-527 | 68382-0527-0168382-0527-0568382-0527-06+2 more | — |
| methylprednisolone | Methylprednisolone 4 mg/1 | TabletOral | 68382-916 | 68382-0916-0168382-0916-0568382-0916-34 | — |
| methylprednisolone | Methylprednisolone 8 mg/1 | TabletOral | 68382-917 | 68382-0917-0168382-0917-0568382-0917-11+1 more | — |
| methylprednisolone | Methylprednisolone 16 mg/1 | TabletOral | 68382-918 | 68382-0918-0168382-0918-0568382-0918-18+1 more | — |
| methylprednisolone | Methylprednisolone 32 mg/1 | TabletOral | 68382-919 | 68382-0919-0168382-0919-0568382-0919-11+1 more | — |
| Memantine hydrochloride | Memantine hydrochloride 7 mg/1 | Capsule, Extended releaseOral | 68382-546 | 68382-0546-0668382-0546-1668382-0546-77 | — |
| Memantine hydrochloride | Memantine hydrochloride 14 mg/1 | Capsule, Extended releaseOral | 68382-547 | 68382-0547-0668382-0547-1668382-0547-77 | — |
| Memantine hydrochloride | Memantine hydrochloride 21 mg/1 | Capsule, Extended releaseOral | 68382-548 | 68382-0548-0668382-0548-1668382-0548-77 | — |
| Memantine hydrochloride | Memantine hydrochloride 28 mg/1 | Capsule, Extended releaseOral | 68382-549 | 68382-0549-0668382-0549-1668382-0549-77 | — |
| Clobetasol Propionate | Clobetasol propionate .5 mg/g | OintmentTopical | 70710-1401 | 70710-1401-0170710-1401-0270710-1401-03+1 more | — |
| minocycline hydrochloride | Minocycline hydrochloride 45 mg/1 | Tablet, Extended releaseOral | 68382-531 | 68382-0531-0168382-0531-0568382-0531-06+3 more | — |
| minocycline hydrochloride | Minocycline hydrochloride 90 mg/1 | Tablet, Extended releaseOral | 68382-533 | 68382-0533-0168382-0533-0568382-0533-06+3 more | — |
| minocycline hydrochloride | Minocycline hydrochloride 135 mg/1 | Tablet, Extended releaseOral | 68382-535 | 68382-0535-0168382-0535-0568382-0535-06+3 more | — |
| minocycline hydrochloride | Minocycline hydrochloride 80 mg/1 | Tablet, Extended releaseOral | 68382-551 | 68382-0551-0168382-0551-0568382-0551-06+3 more | — |
| minocycline hydrochloride | Minocycline hydrochloride 105 mg/1 | Tablet, Extended releaseOral | 68382-552 | 68382-0552-0168382-0552-0568382-0552-06+3 more | — |
| nitrofurantoin macrocrystals | Nitrofurantoin 50 mg/1 | CapsuleOral | 68382-559 | 68382-0559-0168382-0559-1068382-0559-30 | — |
| nitrofurantoin macrocrystals | Nitrofurantoin 100 mg/1 | CapsuleOral | 68382-560 | 68382-0560-0168382-0560-1068382-0560-30 | — |
| Allopurinol | Allopurinol 100 mg/1 | TabletOral | 70710-1209 | 70710-1209-0070710-1209-01 | — |
| Allopurinol | Allopurinol 300 mg/1 | TabletOral | 70710-1210 | 70710-1210-0070710-1210-0170710-1210-05 | — |
| Nifedipine | Nifedipine 30 mg/1 | Tablet, Extended releaseOral | 68382-685 | 68382-0685-0168382-0685-1068382-0685-95 | — |
| Nifedipine | Nifedipine 60 mg/1 | Tablet, Extended releaseOral | 68382-686 | 68382-0686-0168382-0686-1068382-0686-95 | — |
| Nifedipine | Nifedipine 90 mg/1 | Tablet, Extended releaseOral | 68382-687 | 68382-0687-0168382-0687-1068382-0687-95 | — |
| Doxycycline | Doxycycline hyclate 100 mg/10mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68382-910 | 68382-0910-10 | — |
| Doxycycline | Doxycycline hyclate 200 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68382-911 | 68382-0911-01 | — |
| Doxycycline | Doxycycline 50 mg/1 | Tablet, Film coatedOral | 70710-1121 | 70710-1121-01 | — |
| Doxycycline | Doxycycline 75 mg/1 | Tablet, Film coatedOral | 70710-1122 | 70710-1122-01 | — |
| Doxycycline | Doxycycline 100 mg/1 | Tablet, Film coatedOral | 70710-1123 | 70710-1123-0770710-1123-08 | — |
| Doxycycline | Doxycycline 150 mg/1 | Tablet, Film coatedOral | 70710-1124 | 70710-1124-0170710-1124-03 | — |
Zydus Pharmaceuticals USA Inc.: common questions
- What is Zydus Pharmaceuticals USA Inc.'s NDC labeler code?
- 68382, 70710. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Zydus Pharmaceuticals USA Inc.?
- Med-Code's HCPCS directory matches J2778 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.